Nuance Investments LLC Sells 81,634 Shares of Healthpeak Properties, Inc. $DOC

Key Points

• Nuance Investments LLC cut its Healthpeak Properties stake by 35.7%, selling 81,634 shares and retaining 147,135 shares valued at approximately $3.15 million.
• Institutional ownership remains high at 93.57%, with several major investors—including Norges Bank, UBS Asset Management and Bank of New York Mellon—recently increasing their positions.
• Analysts maintain a generally cautious outlook, with a consensus “Hold” rating and $21.44 price target. Healthpeak exceeded quarterly earnings and revenue expectations and announced a monthly dividend yielding about 5.9%.

Nuance Investments LLC reduced its position in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 35.7% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 147,135 shares of the real estate investment trust's stock after selling 81,634 shares during the period. Nuance Investments LLC's holdings in Healthpeak Properties were worth $3,149,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Norges Bank bought a new position in shares of Healthpeak Properties in the 4th quarter valued at $153,550,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in Healthpeak Properties by 694.6% in the third quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 8,016,692 shares of the real estate investment trust's stock valued at $153,520,000 after buying an additional 7,007,777 shares in the last quarter. Bank of New York Mellon Corp boosted its stake in Healthpeak Properties by 60.3% in the first quarter. Bank of New York Mellon Corp now owns 15,456,420 shares of the real estate investment trust's stock valued at $253,949,000 after buying an additional 5,815,189 shares in the last quarter. Fuller & Thaler Asset Management Inc. grew its position in Healthpeak Properties by 19.2% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust's stock valued at $476,744,000 after acquiring an additional 4,776,056 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA grew its position in Healthpeak Properties by 214.0% in the second quarter. Massachusetts Financial Services Co. MA now owns 4,230,551 shares of the real estate investment trust's stock valued at $98,050,000 after acquiring an additional 2,883,382 shares during the last quarter. 93.57% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have commented on DOC. Cantor Fitzgerald boosted their target price on Healthpeak Properties from $20.00 to $23.00 and gave the stock a "neutral" rating in a research note on Thursday, August 6th. Barclays started coverage on shares of Healthpeak Properties in a research note on Tuesday, July 7th. They issued an "equal weight" rating and a $23.00 price target on the stock. Raymond James Financial began coverage on shares of Healthpeak Properties in a report on Wednesday, June 17th. They set a "market perform" rating on the stock. Weiss Ratings reiterated a "hold (c)" rating on shares of Healthpeak Properties in a research report on Wednesday, August 5th. Finally, Wall Street Zen raised shares of Healthpeak Properties from a "sell" rating to a "hold" rating in a research note on Sunday, May 10th. Four equities research analysts have rated the stock with a Buy rating and fifteen have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, Healthpeak Properties has an average rating of "Hold" and a consensus price target of $21.44.

Healthpeak Properties Price Performance

Healthpeak Properties stock opened at $20.60 on Tuesday. The stock has a 50-day moving average price of $21.35 and a two-hundred day moving average price of $18.93. Healthpeak Properties, Inc. has a 12 month low of $15.70 and a 12 month high of $22.95. The company has a market capitalization of $14.20 billion, a PE ratio of 58.86, a P/E/G ratio of 3.20 and a beta of 1.01. The company has a current ratio of 3.02, a quick ratio of 3.02 and a debt-to-equity ratio of 1.06.

Healthpeak Properties (NYSE:DOC - Get Free Report) last released its quarterly earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share for the quarter, topping the consensus estimate of $0.03 by $0.05. Healthpeak Properties had a return on equity of 2.79% and a net margin of 8.24%.The company had revenue of $771.58 million for the quarter, compared to analysts' expectations of $725.64 million. During the same period in the previous year, the business posted $0.46 earnings per share. The business's quarterly revenue was up 11.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. Analysts expect that Healthpeak Properties, Inc. will post 1.77 EPS for the current year.

Healthpeak Properties Dividend Announcement

The firm also recently announced a monthly dividend, which will be paid on Friday, September 25th. Shareholders of record on Monday, September 14th will be issued a dividend of $0.1017 per share. This represents a c) dividend on an annualized basis and a yield of 5.9%. The ex-dividend date of this dividend is Monday, September 14th. Healthpeak Properties's payout ratio is presently 348.57%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source